2 growth stocks owned by this Neil Woodford-beating fund

Can you afford to ignore these two hidden growth champions?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Neil Woodford is considered to be one of the UK’s best fund managers. However, while it is impossible to deny that Woodford’s performance is certainly better than most, there are fund managers out there that have chalked up a better performance over the years.

One such example is the MFM Slater Growth Fund, which has been managed by Mark Slater since March 2005. Over this period, the fund has produced a return of nearly 300% while over the same period funds managed by Woodford have produced a return of around 200%.

Here are two of the top 10 positions.

In demand

First Derivatives (LSE: FDP) is not a company that features heavily on most investors’ radars. The company provides IT services to the financial services industry, a boring but essential line of business. Since the financial crisis, the demand for such services has been growing as regulators clamp down on bad behaviour and companies are forced to find new ways to meet regulatory demands while at the same time keeping costs low.

First Derivatives’ profits have surged over the past few years thanks to this trend. For the financial year ending 28 February 2013, the company reported revenue of £57m and a pre-tax profit of £6.2m. For the year ending 28 February 2017, analysts have pencilled-in a pre-tax profit of £18.1m on revenue of £144m, up 191% and 152% respectively over the five-year period. During this time, earnings per share have grown 86% and shareholders have been well rewarded as the shares are up 125% since the beginning of 2014. 

City analysts are expecting this growth to continue for the next few years. Earnings per share growth of 10% has been pencilled-in for the fiscal year ending 28 February 2018 and further earnings growth of 8% is expected for the following financial year. Between fiscal year-end 2017 and 2019 pre-tax profit is expected to increase by 23%.

This kind of growth is worth paying for and the market has placed a high multiple on the company’s shares as a result. Shares in First Derivatives currently trade at a forward P/E of 47.8 and only yield a paltry 0.7%, which may be too pricey for most investors. Still, if the company can repeat the growth seen in the past few years, over the long term this may be a price worth paying.

Cheap growth 

Like First Derivatives, CVS Group (LSE: CVSG) is another company that has achieved outstanding growth over the past few years, which appears to be why MFM’s managers like the company. 

Between fiscal year-end 30 June 2012 and 30 June 2017, the company is expected to have grown earnings per share by an impressive 167%. Over the same period, pre-tax profit is up by a staggering 771%. Once again, such growth does not come cheap. Shares in CVS are currently trading at a forward P/E ratio of 29.6, falling to 27.2 for 2018. 

Nonetheless, with earnings per share growth of 30% projected for the year ending 30 June 2017, the shares appear to be worth paying a premium for.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »